Peptide Library

FDA-approved

Hormones & metabolism

Mecasermin

Evidence

FDA approved

Class

Recombinant IGF-1

/

Mecasermin

KEY TAKEAWAY

Mecasermin is a recombinant version of human insulin-like growth factor 1 (IGF-1), a 70-amino-acid protein. It is sold as Increlex. The FDA approved mecasermin (Increlex) in 2005 for children with severe primary IGF-1 deficiency or certain growth hormone gene deletions.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Recombinant IGF-1

Approved for

Severe primary IGF-1 deficiency in children

Key fact

The FDA approved mecasermin (Increlex) in 2005 for children with severe primary IGF-1 deficiency or certain growth hormone gene deletions.

Route

Twice-daily subcutaneous injection

Evidence strength

FDA approved

What it is

What it is

Mecasermin is a recombinant version of human insulin-like growth factor 1 (IGF-1), a 70-amino-acid protein. It is sold as Increlex.

How it works

How it works

It replaces IGF-1 in children whose bodies cannot make enough, which allows growth.

Regulatory status

Regulatory status

The FDA approved mecasermin (Increlex) in 2005 for children with severe primary IGF-1 deficiency or certain growth hormone gene deletions.

What it is used for

What it is used for

Severe primary IGF-1 deficiency in children.

Side effects and risks

Side effects and risks

Low blood sugar is the main risk, so it is taken with food. Enlarged tonsils, jaw pain and changes at injection sites are also reported.

Citations

Citations

U.S. FDA prescribing information for Mecasermin. DailyMed, National Library of Medicine.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo